NCT04030962: A reported trial by AbbVie
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04030962 |
|---|---|
| Title | A Multicenter, Vehicle-controlled, Double-Masked, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of AGN-242428 and AGN-231868 in Participants With Dry Eye Disease |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 4, 2020 |
| Completion date | March 18, 2022 |
| Required reporting date | March 18, 2025, midnight |
| Actual reporting date | Feb. 13, 2025 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |